New multiple sclerosis treatment trial compares stem cell transplantation to best available drugs

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

01/07/2020 09:30 AM EST

NIH-funded study focuses on severe forms of relapsing MS.